New Immune Therapy for Colorectal Cancer at Duke

The duke cancer institute center for cancer immunotherapy brings doctors and scientists together to create better cancer treatments using immunotherapy. Immunotherapy helps the body’s immune system find and kill cancer cells. The center works to develop new treatments, find new ways to use existing ones, and combine different drugs to make them more effective. Their goal is to move discoveries from the lab to patient care as quickly and safely as possible.

CAR T-cell therapy is a cancer treatment that helps some lymphoma patients. Doctors take special white blood cells called T cells from the patient, change them in a lab so they can better fight cancer, and then put them back into the body. These changed cells help find and kill cancer cells. Each treatment is made from the patient’s own cells, so it is unique to that person.

This therapy is for people whose lymphoma has not gotten better after at least two other treatments. It is used for several types of non-Hodgkin’s lymphoma. The duke cancer institute was one of the first hospitals allowed to give CAR T-cell therapy after it was approved in 2017 by the U.S. food and drug administration.

CAR T-cell therapy is also being tested for some solid tumors in clinical trials. The preston robert tisch brain tumor center is studying this treatment for glioblastoma, a serious type of brain cancer. Researchers at duke university are also working on new ways to use immunotherapy to better target cancer and help the immune system fight it more strongly.

The duke cancer institute center for cancer immunotherapy wants to work with other researchers to improve cancer treatment. They support projects that turn lab discoveries into treatments for patients. The center also helps scientists build research teams and apply for grants to study new ideas. They are open to collaborations for all types of cancer and new scientific approaches.